title: Eplerenone: another drug to add to the mix?
authors.affiliation: Hennepin County Medical Center, Minneapolis, Minnesota. Electronic address: bartx006@umn.edu.
authors.forename: Bradley A
authors.initials: BA
authors.lastname: Bart
authors.forename: Sarah
authors.initials: S
authors.lastname: Nelson
mesh_terms: D000077545:Eplerenone; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006760:Hospitalization / Q000639:trends*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D051436:Renal Insufficiency, Chronic / Q000139:chemically induced*; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000077545:Eplerenone
keywords: chronic kidney disease; diabetes; elderly; eplerenone; safety